Our results align with previous studies showing that high FOXP3 expression is associated with favorable prognosis in OSCC and HPV-negative HNSCC [23,24], as well as in ovarian and colorectal cancer [40,41,42]. This evidence concerns the gene FOXP3 and colorectal cancer.